How to Report Fake Ozempic / Raw Semaglutide: The MHRA should be alerted to any suspected fake medications or illegal medications being sold to the general public

Semaglutide is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus and weight management Standard blood panels do not detect semaglutide levels as these are not routinely measured in UK clinical practice Ozempic typically reduces HbA1c by 1.01.5% and improves metabolic parameters including lipid profiles and liver enzymes Regular monitoring includes HbA1c every 36 months, annual renal and liver function tests, and assessment for gastrointestinal side effects Patients must inform all healthcare providers about Ozempic use, particularly before surgical procedures due to delayed gastric emptying Table of Contents Understanding Ozempic and Routine Blood Tests Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses under the brand name Wegovy, for weight management in specific patient groups

To find out which injection regimen is the right one for you, and what other treatments might be suitable for reaching your goals, schedule a personalized consultation with us
Symptoms like hair loss, fatigue, flaky skin, or bruising, muscle weakness, poor wound healing may indicate insufficiency (Mozafariun et al 2025)
A peer-reviewed study published in JMIR Formative Research found that participants on Second Natures semaglutide-supported programme lost an average of 17.1% of their body weight at 12 months